Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 2963-2970

  Leconte, Mahaut ^a,b   Nicco, Carole ^a   Ngô, Charlotte ^a,b   Arkwright, Sylviane ^b   Chéreau, Christiane ^a   Guibourdenche, Jean ^b   Weill, Bernard ^a   Chapron, Charles ^b   Dousset, Bertrand ^b   Batteux, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA SMOOTH MUSCLE ACTIN; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIOSIS; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

EID: 78650223334     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100375     Document Type: Article

References (45)

1. Giudice LC, Kao LC: Endometriosis. Lancet 2004, 364:1789-1799
2. Berkley KJ, Rapkin AJ, Papka RE: The pains of endometriosis. Science 2005, 308:1587-1589
3. Chapron C, Bourret A, Chopin N, Dousset B, Leconte M, Amsellem-Ouazana D, de Ziegler D, Borghese B: Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions. Hum Reprod 25:884-889
4. Chapron C, Fauconnier A, Dubuisson JB, Barakat H, Vieira M, Breart G: Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease. Hum Reprod 2003, 18:760-766
5. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ: Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991, 55:759-765
6. Laursen BS, Bajaj P, Olesen AS, Delmar C, Arendt-Nielsen L: Health related quality of life and quantitative pain measurement in females with chronic non-malignant pain. Eur J Pain 2005, 9:267-275
7. De Ziegler D, Borghese B, Chapron C: Endometriosis and infertility: pathophysiology and management. Lancet 2010, 376:730-738
8. Bonte H, Chapron C, Vieira M, Fauconnier A, Barakat H, Fritel X, Vacher-Lavenu MC, Dubuisson JB: Histologic appearance of endometriosis infiltrating uterosacral ligaments in women with painful symptoms. J Am Assoc Gynecol Laparosc 2002, 9:519-524
9. Dousset B, Leconte M, Borghese B, Millischer AE, Roseau G, Arkwright S, Chapron C: Complete surgery for low rectal endometriosis: long-term results of a 100-case prospective study. Ann Surg 251:887-895
10. Ngo C, Chereau C, Nicco C, Weill B, Chapron C, Batteux F: Reactive oxygen species controls endometriosis progression. Am J Pathol 2009, 175:225-234
11. Klein TW: Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005, 5:400-411
12. Bifulco M, Di Marzo V: Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat Med 2002, 8:547-550
13. Guzman M, Sanchez C, Galve-Roperh I: Cannabinoids and cell fate. Pharmacol Ther 2002, 95:175-184
14. Pisanti S, Borselli C, Oliviero O, Laezza C, Gazzerro P, Bifulco M: Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J Cell Physiol 2007, 211:495-503
15. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V: The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 1998, 95:8375-8380
16. Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V: Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 2000, 141:118-126 (Pubitemid 32260350)
17. Gomez del Pulgar T, Velasco G, Sanchez C, Haro A, Guzman M: De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 2002, 363:183-188
18. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P: Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 1995, 312 (Pt 2):637-641
19. Rueda D, Galve-Roperh I, Haro A, Guzman M: The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 2000, 58:814-820
20. Fogli S, Breschi M: The molecular bases of cannabinoid action in cancer. Cancer Ther 2008, 6:103-116
21. Varma R, Rollason T, Gupta JK, Maher ER: Endometriosis and the neoplastic process. Reproduction 2004, 127:293-304
22. Akhmetshina A, Dees C, Busch N, Beer J, Sarter K, Zwerina J, Zimmer A, Distler O, Schett G, Distler JH: The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis Rheum 2009, 60:1129-1136
23. Defer N, Wan J, Souktani R, Escoubet B, Perier M, Caramelle P, Manin S, Deveaux V, Bourin MC, Zimmer A, Lotersztajn S, Pecker F, Pavoine C: The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J 2009, 23:2120-2130
24. Garcia-Gonzalez E, Selvi E, Balistreri E, Lorenzini S, Maggio R, Natale MR, Capecchi PL, Lazzerini PE, Bardelli M, Laghi-Pasini F, Galeazzi M: Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. Rheumatology (Oxford) 2009, 48:1050-1056
25. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S: Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005, 128:742-755
26. Michalski CW, Maier M, Erkan M, Sauliunaite D, Bergmann F, Pacher P, Batkai S, Giese NA, Giese T, Friess H, Kleeff J: Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells. PLoS One 2008, 3:e1701
27. Munoz-Luque J, Ros J, Fernandez-Varo G, Tugues S, Morales-Ruiz M, Alvarez CE, Friedman SL, Arroyo V, Jimenez W: Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther 2008, 324:475-483
28. Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S: CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006, 12:671-676
29. Guindon J, Hohmann AG: Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 2008, 153:319-334
30. Pacher P, Batkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006, 58:389-462 (Pubitemid 44394908)
31. Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM: Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 1996, 70:791-798 (Pubitemid 26009816)
32. Hornung D, Ryan IP, Chao VA, Vigne JL, Schriock ED, Taylor RN: Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab 1997, 82:1621-1628 (Pubitemid 27200445)
33. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, Weill B, Batteux F: Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005, 65:948-956 (Pubitemid 40216456)
34. Song JS, Kang CM, Yoo MB, Kim SJ, Yoon HK, Kim YK, Kim KH, Moon HS, Park SH: Nitric oxide induces MUC5AC mucin in respiratory epithelial cells through PKC and ERK dependent pathways. Respir Res 2007, 8:28
35. Bruner-Tran KL, Webster-Clair D, Osteen KG: Experimental endometriosis: the nude mouse as a xenographic host. Ann NY Acad Sci 2002, 955:328-339; discussion 340-322, 396-406 (Pubitemid 34271090)
36. Grummer R, Schwarzer F, Bainczyk K, Hess-Stumpp H, Regidor PA, Schindler AE, Winterhager E: Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod 2001, 16:1736-1743 (Pubitemid 32761762)
37. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'Argenio G, Scaglione G, Bifulco M, Sorrentini I, Di Marzo V: Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 2003, 125:677-687 (Pubitemid 37070686)
38. Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, Velasco G, Malumbres M, Guzman M: Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 2006, 20:2633-2635
39. Ngo C, Nicco C, Leconte M, Chereau C, Weill B, Batteux F, Chapron C: Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo. Fertil Steril 2009, 94:1632-1638
40. Han KH, Lim S, Ryu J, Lee CW, Kim Y, Kang JH, Kang SS, Ahn YK, Park CS, Kim JJ: CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc Res 2009, 84:378-386
41. Mukhopadhyay P, Rajesh M, Batkai S, Patel V, Kashiwaya Y, Liaudet L, Evgenov OV, Mackie K, Hasko G, Pacher P: CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res 85:773-784
42. Ellert-Miklaszewska A, Kaminska B, Konarska L: Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell Signal 2005, 17:25-37 (Pubitemid 39286777)
43. Jia W, Hegde VL, Singh NP, Sisco D, Grant S, Nagarkatti M, Nagarkatti PS: Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res 2006, 4:549-562
44. McKallip RJ, Nagarkatti M, Nagarkatti PS: Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 2005, 174:3281-3289
45. Sarfaraz S, Afaq F, Adhami VM, Malik A, Mukhtar H: Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem 2006, 281:39480-39491 (Pubitemid 46041908)